Stay updated with breaking news from Brook Baker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nearly a year after the first Covid-19 vaccination campaigns began, the vast majority of the shots have gone to people in wealthy nations, with no clear path toward resolving the disparity. News this month that an antiviral medication had proved effective against the coronavirus in a large clinical trial has brought new hope of a turning point in the pandemic: a
Despite efforts to license molnupiravir to generic-drug firms, the same risks of unequal distribution remain, says report.
(Oct 12): Moves by several countries to buy supplies of Merck & Co’s promising Covid pill before it’s even approved are raising concerns that some poorer nations could be left behind, in a repeat of the slow and inequitable rollout of vaccines.
(Bloomberg) -- Moves by a small group of countries to acquire supplies of Merck & Co.’s promising Covid pill before it’s even approved are raising concerns that some poorer nations could be left behind in a repeat of the slow and inequitable rollout of vaccines.
LONDON -- When global health officials created Covax, a U.N.-backed effort to share coronavirus vaccines, it was supposed to guarantee the world's most vulnerable people could get doses without being at the mercy of unreliable donations.